Position in ANIK
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$244,484
+$70,111 QoQ
Shares Held
16,861
-7.1% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in ANIK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. ANIK ranks #40 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,229,009 | $145,281,153 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
122,486 | $72,631,748 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
303,820 | $40,025,246 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
1,268,203 | $30,348,097 | |
| 5 | VTRS |
Viatris Inc
|
1,941,082 | $26,224,017 | |
| 6 | ALKS |
Alkermes plc.
|
449,531 | $15,895,416 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
194,563 | $14,757,603 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
643,856 | $13,366,450 |
All Filings in ANIK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $244,484 | 16,861 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $174,373 | 18,145 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $190,998 | 20,319 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $224,571 | 21,226 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $317,298 | 21,111 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $366,185 | 22,247 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $552,193 | 22,356 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $613,771 | 24,231 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $615,899 | 24,248 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $571,009 | 25,199 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $484,957 | 26,031 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,343,503 | 51,713 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,416,527 | 49,322 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,356,420 | 45,825 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,078,544 | 45,317 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $977,950 | 43,815 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,081,136 | 43,056 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,506,400 | 42,043 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,802,416 | 42,350 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,027,010 | 46,824 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,069,113 | 50,726 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,197,146 | 48,545 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,546,224 | 43,691 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,757,614 | 46,584 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,449,720 | 50,146 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||